相似文献
1
Other drug treatments: the evidence.
Proc Nutr Soc. 2000 Aug;59(3):425-6. doi: 10.1017/s0029665100000525.
2
Arresting cardiovascular disease progression. Early treatment may counteract high risk.
Postgrad Med. 2004 Aug;116(2):45-8. doi: 10.3810/pgm.2004.08.1570.
3
Optimizing treatment of hypertension in patients with diabetes.
JAMA. 2000 Jun 28;283(24):3177-9. doi: 10.1001/jama.283.24.3177.
4
Follow-up of intensive glucose control in type 2 diabetes.
N Engl J Med. 2009 Jan 22;360(4):417-8; author reply 418.
5
Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
JAMA Cardiol. 2017 Sep 1;2(9):1019-1023. doi: 10.1001/jamacardio.2017.2172.
6
[Hypertension in diabetes mellitus].
Orv Hetil. 2009 Sep 27;150(39):1813-23. doi: 10.1556/OH.2009.28718.
7
Cardiovascular risk in patients with type 2 diabetes.
CMAJ. 2005 Apr 26;172(9):1160-1. doi: 10.1503/cmaj.1050049.
8
The diabetic patient as paradigm for selective antihypertensive therapy.
Clin Cornerstone. 1999;2(1):1-12. doi: 10.1016/s1098-3597(99)90078-9.
9
CAPPP trial. Captopril Prevention Project.
Lancet. 1999 May 22;353(9166):1794-5; author reply 1795-6. doi: 10.1016/s0140-6736(05)75891-8.
10
Recent review highlights implications for prevention of cardiovascular disease.
Cardiovasc J S Afr. 2003 May-Jun;14(3):161-2.
Zotero 插件